VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 150 | -62.5% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +33.3% | 400 | -38.5% | 0.00% | – |
| Q4 2018 | $6,000 | -50.0% | 650 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 650 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +8.3% | 650 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,000 | -7.7% | 750 | +15.4% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | +62.5% | 650 | +62.5% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |